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Antimicrobial resistance is a growing global health concern that 
warrants attention and immediate action.[1] Since their introduction, 
antimicrobial agents have effectively decreased morbidity 
and mortality caused by infectious diseases. Regrettably, their 
inappropriate and irrational use has led to an increased risk of adverse 
drug effects and the development of antimicrobial resistance, which 
renders some antimicrobials ineffective.[2,3] Moreover, a discrepancy 
in diagnostic procedures vital to correctly identifying different 
pathogens aggravates the situation.[2]
Since healthcare settings are associated with the highest 
emergence and spread of antimicrobial resistance,[4] the Infectious 
Diseases Society of America[5] published guidelines recommending 
that all hospitals develop institutional programmes to enhance 
antimicrobial stewardship and hence curb the growing threat of 
antimicrobial resistance. Subsequently, policies and evidence-based 
interventions, such as antimicrobial stewardship programmes 
(ASPs), have been drafted and implemented in various healthcare 
institutions worldwide.[6,7] Antimicrobial stewardship (AMS) refers to 
a collection of strategies and tools to improve clinical outcomes and 
use of antimicrobials, whereby selection of the optimal regimen, dose, 
duration and route of administration is promoted.[8]
AMS programmes are considered an important strategy in the 
fight against antimicrobial resistance.[8] Dyar et al.[9] define AMS as 
a coherent set of actions that promote using antimicrobials in a way 
that ensures sustainable access to effective therapy for all who need 
it. Establishing the impact of an implemented ASP in a healthcare 
facility is important to inform decisions about the future of the 
programme, whether it needs scaling up or not.[10] From evidence, 
impact evaluation studies conducted on the effectiveness of the ASP 
are often limited to individual impact rather than the assessment 
of both individual and organisational impact.[11-14] Furthermore, 
comprehensive impact evaluation of health interventions depends 
on the effectiveness of the programme/intervention, its reach in the 
population, and the extent to which it is properly implemented.[15]
Applying the RE-AIM framework[16] makes it possible to 
comprehensively explore five different impact dimensions that affect 
the ASP: (i) reach for assessing the target population accomplished; 
(ii) effectiveness, i.e. measuring the patient outcomes resulting from 
the programme; (iii) adoption, i.e. measuring the number of target 
settings participating in the study and staff who are responsible for the 
management of the programme in the facility; (iv) implementation, 
i.e. consistency and cost of delivery; and (v) maintenance of the 
intervention’s positive effects over time.[16] The RE-AIM framework 
is useful for determining which interventions work in real-world 
settings and assesses impact at individual and organisational levels. [17] 
Although there is evidence of the effectiveness of ASPs in the 
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Staphylococcus aureus (n=6; 22.2%), Escherichia coli (n=4; 14.8%), Acinetobacter baumannii (n=4; 14.8%) and Streptococcus pnuemoniae 
(n=3; 11.11%), as well as 10 other bacterial species (37.0%) including Corynebacterium species, Enterococcus faecium, Haemophilus 
influenzae, Klebsiella species, Clostridium difficile and Salmonella species. Of the 27 pathogens isolated, 19 (70.4 %) were resistant to the 
prescribed antimicrobials. The overall impact of the ASP implemented in the studied facility was 67.2%.
Conclusions. An ASP requires both thorough implementation and leadership support to have an impact in the reduction of antimicrobial 
resistance. Lack of leadership support poses a significant challenge to sustainability. There is an urgent need for behavioural change in 
hospital leadership.
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literature, the scope of evaluation is narrow and limited to hospital 
length of stay, readmission, re-infection, mortality and emergence 
of resistance,[1] and also economic effects of inappropriate use of 
antimicrobials.[2] To our knowledge, there is a dearth of literature 
on comprehensive evaluation of ASPs integrated into routine use in 
South African (SA) hospitals.
Objectives
To advance understanding of the factors that influence the successful 
implementation and effectiveness of an ASP in limiting the spread of 
antimicrobial resistance in hospitals, a descriptive quasi-experimental 
study guided by the RE-AIM framework was conducted to inform 
best practice.
Methods
Study design and sampling
A descriptive quantitative quasi-experimental study of the quality 
of antimicrobial prescribing was undertaken in an adult intensive 
care unit (ICU) of a large academic hospital in Johannesburg, 
SA, over a 3-month period from June 2017 to August 2017. The 
hospital has ~3 200 beds, and the average length of stay is 7.9 days. 
Systematic random sampling was used to identify study sites from a 
list of tertiary and academic hospitals in Gauteng Province. From this 
process, two academic hospitals were selected, and of these only one 
public hospital agreed to participate in this study.
The sample comprised 65 adult patients (≥18 years) who were 
admitted to the ICU and had received the study recruitment letter.
Study procedures
The study recruitment letter was shared with eligible patients at 
the participating hospital. An invitation letter was also sent to the 
ICU head and ASP team, as they were to complete the institutional 
capacity evaluation questionnaire. Participation in the study was 
voluntary, and all patients and/or their families were asked to provide 
written consent prior to data extraction from the patient’s hospital 
records. Participants were assured of confidentiality and anonymity, 
and were also told of the option to withdraw at any stage of the study.
Measures
A paper-based questionnaire was used to collect patients’ data 
from their hospital records. The questionnaire development was 
informed by reviewed literature, existing surveys and published 
guides pertaining to the ASP.[5,18,19] The reliability of the data 
collection instrument was tested prior to use, and this considered the 
item total correlation, inter-item correlation and Cronbach’s alpha 
coefficient. The developed questionnaire consisted of three phases 
with a total of 41 items. The first phase included 11 items designed to 
collect information concerning the appropriateness of antimicrobials 
prescribed in the ICU and patients’ demographic characteristics. 
The second phase included 7 items concerning the outcome of 
the patients treated with antimicrobials. The third phase included 
23  items on the capacity of the hospital to prescribe antimicrobials 
appropriately. The questionnaire items were closed-ended but offered 
an opportunity for detailed responses.[20]
The RE-AIM framework dimensions were defined and calculated 
and formed the basis of the overall institutional evaluation of the ASP. 
Reach of the programme was calculated as the number of willing and 
participating patients divided by the total number of eligible patients 
whose records were available for analysis.[21]
Effectiveness of the impact of the ASP on important patient 
outcomes was also measured at an individual level. This involved 
assessment of all outcomes that resulted from the use of antimicro-
bials. The number of patients who developed antimicrobial resistance 
was expressed as a percentage of the total participants.
Adoption was assessed as an organisational measure of 
representativeness and characteristics of participating institution 
settings. The adoption dimension calculated the hospitals that 
participated in the study as a percentage of eligible hospitals.[22]
The implementation dimension evaluates the extent to which the ASP 
is delivered as intended at the organisational level.[16] This was achieved 
by assessing the steps taken to prescribe appropriate antimicrobials 
as specified in guidelines.[23] The core elements of hospital antibiotic 
stewardship programmes[18] (leadership commitment, accountability, 
drug expertise, action, tracking, reporting and education) were assessed 
and scores were provided for each core element as follows: deficient (0 - 
25%), low (26 - 50%), sufficient (51 - 75%) or satisfactory (76 - 100%).
The maintenance dimension was excluded because the duration of 
the collection of data was <6 months, the period required to measure 
the long-term effects of a programme.
Subsequent to the evaluation of each of the RE-AIM dimensions, 
the potential effectiveness of the implemented ASP was assessed. The 
total scores of each RE-AIM dimension were added and divided by 5. 
The results thereof was considered to reflect the potential impact of 
the ASP.[24]
Ethical considerations
The study received ethical approval from the Higher Degrees 
Research Ethics Committee of the Department of Health Studies at 
the University of South Africa, Pretoria (ref. no. HSHDC/605/2017).
Statistical analysis
Data were analysed using SPSS version 24 (IBM, USA). Descriptive 
statistics were used to summarise responses to the questionnaire 
questions. Data relating to demographic characteristics of participants, 
susceptibility of bacterial isolates, processes of antimicrobial 
prescribing, capacity and impact measures of the ASP were presented 
as frequencies and percentages. Means and standard deviations were 
used to summarise continuous variables. Multivariate logistical 
regression analysis was used to establish the relationship between risk 
factors and hospital-acquired infections. A  confidence level of 95% 
was used in calculations.
Results
Demographic characteristics
A total of of 59 respondents had complete records and were included 
in the study, with the majority (57.6%) in the 19 - 38-year age group; 
males comprised 55.9% and black Africans 81.4%, 52.5% were 
trauma patients, 45.8% had moderate severity of illness, and 67.8% 
had indications for surgical prophylaxis (Table 1).
Effectiveness of the ASP
The majority of the biological specimens cultured (74.6%) were 
positive for microbial agents. Two patients were admitted because of 
infections, and 21 developed hospital-acquired infections (HAIs); all 
were prescribed antimicrobials during their stay in the ICU.
Table 2 shows the susceptibility results of the pathogens isolated 
from the samples of patients admitted to the ICU. Among the 
21 patients with HAIs, 27 pathogens were isolated. The most 
frequent bacterial species isolated was Staphylococcus aureus (n=6; 
22.2%), followed by Escherichia coli (n=4; 14.8%), Acinetobacter 
baumannii (n=4; 14.8%) and Streptococcus pnuemoniae (n=3; 
11.1%). The least frequently isolated pathogens, all with single 
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isolates (3.7%), included Corynebacterium species, Enterococcus 
faecium, Haemophilus influenzae, Klebsiella species, Clostridium 
difficile and Salmonella species. Of the 27 isolated pathogens, 
19 (70.4%) were resistant to the prescribed antimicrobials. All 4 
A. baumannii isolates (14.8%), 4 (66.7%) of the S. aureus and 50% 
of the E. coli were resistant.
Adoption of the ASP
There were 8 eligible academic hospitals in Gauteng Province; of 
these, 2 were recruited for the study, but only 1 agreed to participate.
The recommended number of trained and educated multi-
disciplinary ASP core members for implementation of the programme 
is 6. In the present study, 5 AMS members (83.3%), including an 
infection prevention and protection physician, a microbiological 
laboratory specialist (leader), a clinician with an interest in infection 
and a pharmacist with expertise in infection, were identified (with 
the exception of nursing staff). There was evidence of the availability 
of local antimicrobial guidelines. The microbiological laboratory was 
situated in the enclosure of the healthcare facility for timely reporting 
of the results.
Implementation of the ASP
The results for the implementation dimension are shown in Table 3. 
The majority (n=10; 71.4%) of the steps for prescribing quality 
antimicrobials were delivered as intended, with the exception of 
4 steps (28.6%). Most patients (n=57; 96.6%) were administered 
antimicrobials intravenously.
The capacity measures for prescribing antimicrobials are presented 
in Table 4. The capacity measure factoring in seven parameters was 
calculated to be 69.2%, indicative of a sufficient capacity to prescribe 
quality antimicrobials. The leadership component scored the lowest 
at 50.0%.
RE-AIM impact outcome measure
Table 5 shows the performance measures of the ASP for each RE- 
AIM dimension. For the reach dimension, a high performance rate of 
90.8% was observed. For the effectiveness dimension, the programme 
performed fairly well, with 56.8% of patients not developing HAI, 
indicating some success in preventing the development of HAI. The 
ASP in the studied facility had a high adoption rate of 83.3%, supported 
by the in-house microbiological laboratory, with a comprehensive list 
of essential antimicrobials and antimicrobial prescribing guidelines. 
There was a 71.4% success rate in following the steps recommended for 
prescribing quality and effective antimicrobials. The implementation 
rate of the ASP in the hospital overall was classed as good.
Discussion
ASPs are an important strategy in the fight against antimicrobial 
resistance.[8] There is a dearth of literature evaluating the impact of the 
ASP, an important step in effective and sustainable implementation 






Mean (SD) 41.51 (16.6)
19 - 38, n (%) 34 (57.6)
39 - 58, n (%) 16 (27.1)
59 - 78, n (%) 7 (11.9)
79 - 98, n (%) 2 (3.4)
Race, n (%)




Diagnosis grouping, n (%)
Infectious diseases 2 (3.4)
Genitourinary system 4 (6.8)
Respiratory system 6 (10.2)
Digestive and liver 11 (18.6)
Trauma 31 (52.5)
Circulatory system 2 (3.9)
Endocrine, nutritional and metabolic 3 (5.1)





Indication of treatment, n (%)
Medical prophylaxis 16 (27.1)
Surgical prophylaxis 40 (67.8)
Therapeutic 3 (5.1)
Table 2. Frequencies and susceptibility of bacterial species isolated from microbiological samples in intensive care unit inpatients (N=27)
Pathogen Resistant, n (%) Sensitive, n (%) Total, n (%)
Acinetobacter baumannii 4 (14.8) - 4 (14.8)
Clostridium difficile - 1 (3.7) 1 (3.7)
Clostridium spp. - 2 (7.4) 2 (7.4)
Corynebacterium 1 (3.7) - 1 (3.7)
Escherichia coli 2 (7.4) 2 (7.4) 4 (14.8)
Enterococcus faecium 1 (3.7) - 1 (3.7)
Enterobacter spp. 2 (7.4) - 2 (7.4)
Haemophilus influenzae 1 (3.7) - 1 (3.7)
Klebsiella 1 (3.7) - 1 (3.7)
Staphylococcus aureus 4 (14.8) 2 (7.4) 6 (22.2)
Streptococcus pneumoniae 2 (7.4) 1 (3.7) 3 (11.1)
Salmonella 1 (3.7) - 1 (3.7)
Total 19 (70.4) 8 (29.6) 27
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Table 3. Processes of quality antimicrobial prescribing
Process Performed Skipped
Indication for antimicrobial use ✓
Obtain cultures ✓
Antimicrobial choice
Target the most likely pathogen ✓
Assess likelihood of resistance ✓
Review contraindication (allergy) ✓
Select antimicrobial with adequate tissue penetration ✓
Aim for a single antimicrobial with desired spectrum ✓
Appropriate antimicrobial dosage ✓
Appropriate dose frequency ✓
Appropriate route ✓
Therapeutic drug monitoring ✓




Total, n (%) 10 (71.4) 4 (28.6)
Table 4. Capacity measures of antimicrobial stewardship programme
Key elements Yes, n No, n Total, n % Characterised
Leadership 1 1 2 50 Low
Accountability 1 0 1 100 Satisfactory
Drug expertise 5 2 7 71. 4 Sufficient
Action 11 6 17 64.7 Sufficient
Tracking 6 2 8 75.0 Sufficient
Reporting 2 1 3 66.7 Sufficient
Education 1 0 1 100 Satisfactory
Total 27 12 39 69.2 Sufficient
Table 5. Impact measures of RE-AIM dimensions 
Dimension Description Evaluation criteria Evaluation
Reach Ratio of participating ICU patients to number of 
patients recruited
Eligible patients recruited n=56
Participating patients n=59
Performance rate 90.7%
Effectiveness Ratio of inpatients who developed HAI to number of 
patients tested for HAI
Biological samples tested n=44
HAI-positive samples n=19
Performance rate 56.8%
Adoption Organisational measure of the number and 
representativeness of staff and settings who have 
adopted the programme, as well as institutional 
support in programme delivery
Eligible recruited facilities n=2
Participating facilities n=1
Settings 50.0%
ASP team members n=5
Recommended ASP team members n=6
Adoption rate 83.3%
ASP staff 66.7%
Implementation Organisational measure of the resources and the extent 
to which ASP was delivered as intended
Steps taken for prescribing antimicrobials n=10
Steps required for prescribing 
antimicrobials
n=14
Processes success rate 71.4%
Core elements of ASP 69.2%
Fidelity rate 70.3%
Average impact (R+E+A+IM)/4 ASP impact 71.1%
RE-AIM = reach, effectiveness, adoption and implementation; ICU = intensive care unit; HAI = hospital-associated infection; ASP = antimicrobial stewardship programme.
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of the programme. The present study describes the application of 
the RE-AIM framework in evaluation of the impact of an ASP in 
reducing the spread of antimicrobial resistance in Gauteng, SA. 
Guided by the RE-AIM framework, four dimensions were considered 
for the impact of the ASP: reach and effectiveness were analysed at 
the individual level, whereas adoption and implementation were 
assessed at the organisational level. Overall, the impact of the ASP 
in limiting the spread of antimicrobial resistance was significantly 
sufficient.
The programme reached ~90% of eligible patients admitted 
to the ICU. This was exceptional considering the barriers to 
recruiting critically ill patients and distrust of researchers concerning 
confidentiality of private information. Reach was substantially greater 
for black African patients than for other ethnic groups, and this could 
be attributed to more black and coloured people using public health 
facilities compared with the white and Indian population, who 
mainly use private health facilities.[25]
Most patients whose records were reviewed were <65 years of age. 
This was a surprising finding, as the global population is ageing, 
so an increase in admission of elderly patients to ICUs would be 
expected.[26] Furthermore, the elderly are commonly admitted to the 
ICU as a result of conditions that result in a compromised immune 
system, such as organ and tissue dysfunction and underlying chronic 
diseases.[27]
The adoption rates in the present study were limited to the one 
of the eight eligible academic hospitals that fully participated. 
The other hospitals therefore missed the opportunity to assess the 
comprehensive impact of the ASP implemented in their institution, 
and therefore to determine the problematic areas. To improve on 
the performance of an ASP, it is recommended that the ASP team 
should include, at a minimum, a physician, a pharmacist, a clinical 
microbiologist and an infection prevention and protection physician, 
with at least one member having experience in AMS.[5,28] The 
participating facility in this study had five healthcare professionals 
as core members of ASP team, i.e. an infection prevention and 
protection physician, a microbiological laboratory specialist (leader), 
clinicians with an interest in infection, and a pharmacist with 
expertise in infection. However, the composition of the core team 
members may vary. In the UK, for example, where infection specialist 
experts are utilised, AMS is viewed as the responsibility of all 
healthcare professionals, not just the ASP team.[28]
Adherence to the guidelines of prescribing antimicrobials in 
the healthcare facility is imperative so as to limit the emergence of 
antimicrobial resistance. The present study reported a high threshold 
in adhering to the recommendations for prescribing antimicrobials, 
suggesting that a remarkable amount of care is devoted to ensuring 
effective and responsible prescribing of antimicrobials to reduce 
antimicrobial resistance. Moreover, there is a strong association 
between adherence to antimicrobial prescribing guidelines and 
prudent use of antimicrobials, implying that adhering to the 
recommended guidelines can reduce inappropriate use or overuse of 
antimicrobials.[29]
The present study illustrates the use of the core elements of an ASP 
for assessing implementation, and suggests that the core elements 
adequately capture the essence of the inputs for the functioning of 
the programme. Overall, the inputs for the implementation of the 
programme were found to be sufficient at 69.2%. Most core elements 
showed sufficient scores of maintenance (51 - 75%), with the exception 
of the leadership element with a low value of 50.0%, suggesting that 
a sufficiently sustainable programme is implemented in the hospital. 
Owing to low leadership support, the organisation lacks personnel 
and funding, which is perceived as the major barrier to a sustainable 
programme. Hospital leadership support is essential to the success 
of an ASP by ensuring that the programme has sufficient budget, 
technology, time management and resources. [30,31] Furthermore, with 
no formal funding available for running the programme, the health 
institution depended on sponsorships for financing.
Study limitations
This study had some limitations. The collection of information from 
adult patients only means that the results are not generalisable to 
paediatric patients. The fact that there was only a single participating 
hospital may not allow the generalisation of the results to other 
hospital settings and the country at large.
The data collection period was not long enough to monitor the long-
term outcome of the patients or determine the programme’s inclusive 
effectiveness. A longer study duration may have demonstrated 
more meaningful results by showing maintenance of the patients’ 
improvement or re-admission to the hospital and identifying the 
causes thereof. However, one of the strengths was that being in one 
centre ensured comprehensive data collection, and the results can be 
used in future comparative studies.
Conclusions
There is ample evidence in the literature that an effective and well-
adopted and implemented ASP can result in more appropriate use 
of antimicrobials, leading to improved patient safety and outcomes. 
Although the present study showed that the performance of the ASP 
implemented in the facility investigated was sufficient, there are 
strategies that can be used to optimise the programme. The study 
demonstrated that regular evaluation of the health programme is 
a necessity for identifying weaknesses and strengths in order to 
upscale it.
The studied facility had no adequate management support for the 
implemented ASP. There was no financial and personnel support 
to sustain the programme, and most of the healthcare workers 
were discouraged from participating in it, leading to inadequate 
performance of the programme. Leadership support is critical for the 
success of ASPs, and it is therefore recommended that the hospital 
leadership should be persuaded to be more concerned about their 
importance.
Recommendations for future research
Owing to the limitations of this study, future research should 
consider including both public and private hospitals, broadening the 
scope to include different types of ICUs and patients, and conducting 
further studies with larger sample sizes and multicentre sampling. 
It is further recommended that the study duration be increased, 
allowing follow-up studies. For a more thorough impact evaluation, 
the measure of cost-effectiveness (the worth of the programme) is 
also recommended to assess whether the benefits outweigh the cost. 
For a comprehensive and more robust evaluation, it is recommended 
that all five RE-AIM dimensions be assessed in future studies.
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